Abstract Desquamation in the mammalian skin is a wellbalanced process of producing corneocytes and shedding them from the surface of the skin. The corneodesmosome, which is a modifi ed desmosome, is the main adhesive structure in the cornifi ed cell layer. The major extracellular constituents of corneodesmosomes are desmoglein 1, desmocollin 1, and corneodesmosin. Proteases involved in the degradation of corneodesmosomes and their inhibitors are secreted from lamellar granules in the granular cell layer. Genetic defects in corneodesmosin and protease inhibitors result in accelerated desquamation and severe barrier impairment. Abnormalities in transportation and secretion of lamellar granules underlie ichthyosis seen in certain human diseases.
Introduction
The skin is the largest organ in the body, and its main function is to cover and protect the body. The protective skin functions reside largely in the stratum corneum of the epidermis, the most superfi cial layer of the skin.
1,2 For a long time, the "bricks and mortar" model proposed by Elias 3 has been used to understand the basic structure and function of stratum corneum. In this model, bricks are the cornifi ed cells and the mortar is the intercellular lipid, which provides both barrier and cohesive functions. However, a component missing in this model has been drawing more attention recently because of its role as the most crucial cell adhesive structure of the stratum corneum. That structure is the corneodesmosome (or corneosome). 4, 5 Strictly controlled degradation of corneodesmosomes is the key factor for a steady Accelerated corneodesmosome degradation results in barrier defects, and delayed degradation leads to hyperkeratosis (ichthyosis). Interestingly, major players in the formation and degradation of corneodesmosomes are provided by lamellar granules (LGs), which are secreted from the granular cells of the epidermis. It has recently been revealed that abnormal transportation and/or secretion of
LGs could result in ichthyosis. In this review, we give a synopsis of the current research fi ndings regarding the formation and degradation of corneodesmosomes and transportation/secretion of LGs, as well as the pathological mechanisms of some diseases related to corneodesmosomes and LGs.
Corneodesmosomes
Found in the stratum corneum, the corneodesmosome is a modifi ed form of desmosome that differs ultrastructurally (Figs. 1A-C, 2). 4, 7 There is an electron-dense midline structure in the extracellular parts (desmoglea) of desmosomes. When desmosomes are transformed into corneodesmosomes between the stratum granulosum and the stratum corneum, the desmoglea loses its trilamellar structure and becomes homogeneously electron dense. On the cytoplasmic side, the attachment plaque (desmosomal plaque) becomes incorporated into the cornifi ed cell envelopes in corneodesmosomes. Keratin fi laments are connected to the attachment plaque in desmosomes, whereas this association is no longer visible in corneodesmosomes in the cornifi ed cells.
Desmosomes are composed of several cytoplasmic and transmembrane proteins. 8, 9 The latter are members of the cadherins families known as desmogleins and desmocollins. Desmoglein 1 and desmocollin 1 constitute the extracellular parts of corneodesmosomes as well. [10] [11] [12] [13] In corneodesmosomes, there is a unique extracellular component known as corneodesmosin. Cleavage of desmoglein 1, desmocollin 1, and corneodesmosin in the stratum corneum by kallikreins and cathepsins is a key step in desquamation (see following). Corneodesmosin is a 52-to 56-kDa glycoprotein produced by keratinocytes. 11, 14 It is stored and secreted by LGs. After the secretion from the apical cell surface of granular cells, corneodesmosin is localized in the extracellular structures of corneodesmosomes and covalently cross-linked to the cornifi ed cell envelopes. This step coincides with the morphological transformation of desmosomes into corneodesmosomes. In vitro studies suggest that corneodesmosin mediates homophilic binding to counterparts on adjacent corneocytes. 15 During corneocyte maturation, corneodesmosin is progressively proteolyzed. Its actual function as an adhesive molecule has recently been revealed by the generation of corneodesmosin knockout mice (see below). Corneodesmosin is cleaved by kallikrein-related peptidases (KLKs) and cathepsins. [16] [17] [18] Lamellar granules (LGs)
LGs (or lamellar bodies, Odland bodies, membrane-coating granules, keratinosomes) are membrane-bound cytoplasmic organelles found in the spinous and granular cells of the epidermis (Fig. 1A,D) . 19, 20 In transmission electron microscopy images, LGs appear as round or oblong granules of 300-400 nm in length and 100-150 nm in width. They show characteristic ordered, lamellate internal structures. In the granular layer, lamellar granules are fused with the plasma membrane and secrete their contents into the intercellular space.
LGs contain various molecules, including lipids, proteases, protease inhibitors, antimicrobial peptides, and corneodesmosomal proteins.
Elias et al. used lipase cytochemistry techniques to show that LGs are continuous with tubular structures of the trans-Golgi network (TGN). 21 Norlen also suggested that TGN and LGs are continuous membrane structures. 22 Our observation supported the notion that LGs are continuous with TGN. 23, 24 We have also shown that the LG molecules are expressed and transported sequentially and separately. Interestingly, KLKs, lymphocyte-epithelial Kazal-type related inhibitor (LEKTI), cathepsins, cystatins, and corneodesmosin involved in regulation of corneocyte desquamation are all LG molecules.
Transportation mechanisms for lamellar granules
Very little is known about the mechanisms for maturation, transportation, and secretion of LGs. A decline in cation (calcium and potassium) gradients across the epidermis stimulates the initial secretion of LGs that occurs in response to barrier disruption. 25 We have suggested that Rab11 may be involved in LG transportation. 26 Studies of two recently identifi ed genetic human diseases have shown that SNARE molecules are involved in LG transportation and secretion (see following). Sando et al. suggested that caveolins may play a role in LG assembly, traffi cking, and/or fusion. 27 Roelandt et al. proposed the "caveolae brake hypothesis" wherein caveolin-1 delivery to the apical plasma membrane of the outermost stratum granulosum arrests LG secretion and induces cornifi cation. 28 
Desquamation enzymes
A number of different proteases of the serine, cysteine, or aspartic protease families have been identifi ed in the differentiated keratinocytes. 29 Among these, KLKs and cathepsins are two groups of proteases implicated in desmosome degradation. KLKs constitute a family of 15 (chymo)trypsin-like serine proteases (KLK1-15) and function through proteolytic cascades. [30] [31] [32] [33] In the skin, at least eight KLKs, including KLK5 (stratum corneum tryptic enzyme) and KLK7 (stratum corneum chymotryptic enzyme), are expressed and secreted to the extracellular space at the transition point between the granular and cornifi ed layers.
34
KLK14 is unique in its high expression in the plantar epidermis. 35 Because KLK5 can activate itself as well as other KLKs, KLK5 is considered to be the initiator of KLK cascades. 30, 36 It is assumed that KLK5 is autoactivated in the stratum granulosum, but its activity is quenched by immediate binding of fragments of LEKTI, a KLK inhibitor in the skin. Dissociation of the KLK5-LEKTI complexes and release of active KLK5 enzyme occur as it diffuses into the stratum corneum. Then, KLK5 activates KLK7 and KLK14. 30 Active KLK5, KLK7, and KLK14 can digest corneodesmosomal components.
33 KLK7 directly cleaves desmocollin 1 and corneodesmosin but is unable to degrade desmoglein 1. KLK5 induces degradation of all three components. Various factors controlling proteolytic degradation of corneodesmosomes by KLKs include protease inhibitors (see below), relative humidity, and pH gradient. [37] [38] [39] Two cysteine proteases, cathepsin V (also called cathepsin L2 or stratum corneum thiol protease) and cathepsin L-like enzyme, 17 and one aspartic acid protease known as cathepsin D, are all involved in corneodesmosomal degradation. 18, 40 Cathepsin V is an LG molecule localized at desmosomes after secretion. 41 Cathepsin D is also an LG protein, 24 but cathepsin L is not an LG protein, even though it is localized in the cytosol. 41 
Desquamation enzyme inhibitors
Wide varieties of protease inhibitors are also present in the epidermis and are implicated in the regulation of desquamation-associated proteolysis. LEKTI is a 15-domain serine protease inhibitor encoded by the SPINK5 gene. 42 It is expressed in the granular layer of the epidermis and transported by LGs into the extracellular space. 23 Its fragments inhibit epidermal KLK5, -7, and -14, forming a tight binding complex. 37 A model in which pH controls KLK activities by regulating their interaction with LEKTI has been proposed. 37 According to this model, in the deep stratum corneum, neutral pH allows strong interaction between LEKTI and its KLK targets, thus preventing corneodesmosomal cleavage. As the pH acidifi es, moving upward, LEKTI and KLK5 dissociate, allowing proteases to progressively degrade its corneodesmosomal targets.
LEKTI2 (SPINK9) is a recently identifi ed KLK5-specifi c inhibitor strongly expressed in the palmoplantar epidermis. 43, 44 Two other serine protease inhibitors, thought to be involved in desquamation control, are skin-derived antileukoproteases (SKALP), also known as elafi n, and secretory leukocyte protease inhibitor (SLPI). 45 Both inhibitors have the ability to effectively reduce desquamation in vitro. In particular, SLPI is a potent inhibitor of KLK7. Cystatin M/E is a cysteine protease inhibitor. 41, 46 It inhibits cathepsin V involved in desquamation (see above). Cystatin M/E is highly expressed in the epidermis and it is secreted by LGs. After secretion, it colocalizes with cathepsin V on (corneo) desmosomes. Alpha-2 macroglobulin-like 1 (A2ML1) is a novel epidermal pan-protease inhibitor expressed in the granular layer and secreted by LGs. 47 It can bind KLK7 and may also bind cathepsin L2 and cathepsin L-like enzyme. This evidence suggests that A2ML1 may play a role in controlling the desquamation process. Cholesterol sulfate acts as a potent inhibitor of serine proteases. 48 Zn 2+ is also a very potent inhibitor of different KLKs, including KLK5 and KLK7. 49, 50 
Abnormalities in desquamation enzyme inhibitors
Netherton syndrome is a rare autosomal recessive disease characterized by severe ichthyosis, hair shaft defects (bamboo hair), and atopic features caused by mutations in the SPINK5 gene encoding LEKTI (Table 1) . Insuffi cient LEKTI activity results in increased proteolytic activity of KLKs. 51 Clinical manifestations correlate with SPINK5 gene mutations. 52 In normal skin, LEKTI-derived inhibitors prevent corneodesmosomes from being destroyed immediately after the secretion of KLKs. In the Netherton syndrome, as soon as KLKs are released, desmosomal components undergo proteolytic digestion and premature desquamation. 13, 51 A null mutation in the cystatin M/E gene in mice results in abnormalities in cornifi cation and desquamation as well as neonatal lethality (see Table 1 ).
53,46

Abnormalities of desquamation enzymes
Transgenic mice that express excessive KLK7 show a scaly skin phenotype with epidermal hyperplasia, dermal infl ammation, and severe pruritus (see Table 1 ). 54 Mice defi cient in cathepsin D showed impaired stratum corneum morphology as well. 55 
Abnormal corneodesmosomes
What would happen if corneodesmosomal adhesion molecules were abnormal? In the case of desmoglein 1, there is a disease caused by dominant mutations in the gene, namely, striate palmoplantar keratoderma. 56 Electron microscopy has revealed signifi cantly reduced numbers of desmosomes in the suprabasal layers and decreased desmosome size, but no abnormalities in stratum corneum structure or in the desquamation process have been reported. 57 Desmocollin 1 knockout mice have been generated, and the mice developed acantholysis and hyperproliferation of the epidermis. 58 The stratum corneum was thickened, probably the result of hyperproliferation.
Until very recently, it was not known what would happen if the corneodesmosin gene were missing. Two independent groups produced corneodesmosin knockout mice. 59, 60 The mutation was lethal and the mice died within several hours of birth. In the skin, early detachment of the stratum corneum and structurally abnormal corneodesmosomes were found. The desmoglea was not electron dense when compared with that of wild-type mice. 59 This fi nding clearly demonstrates that corneodesmosin is a crucial molecule for corneocyte adhesion.
Abnormal LG transportation and secretion
There are two diseases with ichthyosis characterized by abnormal LG transportation. The fi rst one is a new and rare autosomal recessive disease called CEDNIK syndrome. 61 CEDNIK stands for cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma, all of which are characteristics of this disease. CEDNIK is caused by a lossof-function mutation in the SNAP29 gene coding a SNARE protein. SNARE proteins mediate membrane fusion between vesicles and target membranes, and the SNAP29 molecule is involved in intracellular traffi cking steps between the Golgi apparatus, the TGN, and the plasma membrane. A large family of SNARE proteins consists of two types: v-SNARE located on vesicular membranes and t-SNARE on the target membranes. 62 Within the t-SNARE protein type, there is a syntaxin family and a SNAP-25 family, of which SNAP29 is a member.
To see the pathological mechanisms of ichthyosis in CEDNIK syndrome and to gain some insight into the functions of SNAP29 in the epidermis, we examined skin samples from patients using electron microscopy. There were countless clear vesicles or abnormal granules in the spinous, granular, and cornifi ed cells. Immunoelectron microscopy revealed that abnormal granules in CEDNIK cornifi ed cells contain unsecreted LG-molecules such as glucosylceramides and KLK7. From these observations, we concluded that SNAP29 may be involved in the maturation, transportation, and secretion of LGs.
The other disease belonging to this category is also a rare autosomal recessive disorder known as ARC syndrome. 63, 64 In addition to arthrogryposis, renal dysfunction, and cholestatic jaundice, patients develop severe ichthyosis. The nature of this ichthyosis has not yet been elucidated. We, therefore, looked at skin specimens and found abnormalities in LG secretion.
LGs in the spinous and granular cells appeared normal, but a number of entombed LG-like structures were found in the stratum corneum. ARC syndrome is caused by a loss-of-function mutation in VPS33B. VPS33B is a protein that regulates SNARE protein-mediated membrane fusion. It binds to t-SNARE, determining the specifi city of this membrane fusion process. In ARC syndrome, ichthyosis is likely to be caused by abnormal secretion of
LGs and delayed desquamation. These data suggest that VPS33B may regulate transportation and/or secretion of
LGs.
Conclusion
We have reviewed factors involved in the process of desquamation and their abnormalities. This knowledge is essential to develop effective strategies to correct abnormal desquamation processes in various skin diseases including ichthyosis and keratoderma.
